© 2004 by Oxford University Press
© 2004 Oxford University Press
ARTICLE |
Helicobacter pylori Infection and Gastric Atrophy: Risk of Adenocarcinoma and Squamous-Cell Carcinoma of the Esophagus and Adenocarcinoma of the Gastric Cardia
Affiliations of authors: Department of Medical Epidemiology and Biostatistics (WY, MH, JL, LE, ON), Microbiolgy and Tumor Biology Center (LE), Karolinska Institutet, Stockholm, Sweden; International Epidemiology Institute, Rockville, MD (WJB, JKM); Department of Surgery, Karolinska Hospital, Stockholm (JL); Swedish Institute for Infectious Disease Control, Stockholm (LE); Department of Medicine, Vanderbilt University, Nashville, TN (WJB, JKM).
Correspondence to: Weimin Ye, MD, PhD, Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Box 281, SE171 77, Stockholm, Sweden (e-mail: weimin.ye{at}meb.ki.se)
Background: An inverse association between Helicobacter pylori infection and esophageal adenocarcinoma has been reported that may be attributed to reduced acidity from inducing atrophic gastritis and from producing ammonia. We examined associations between H. pylori infection, gastric atrophy, and the risk of esophageal adenocarcinoma, esophageal squamous-cell carcinoma, and gastric cardia adenocarcinoma in a large population-based case-control study in Sweden. Methods: Self-reported data were obtained during interviews, and serum was collected from 97 patients with incident esophageal adenocarcinoma, 85 patients with incident esophageal squamous-cell carcinoma, 133 patients with incident gastric cardia adenocarcinoma, and 499 randomly selected control subjects. Serum antibodies against whole H. pylori cell-surface antigens (HP-CSAs) and cytotoxin-associated gene A (CagA) antigens were assessed by an IgG enzyme-linked immunosorbent assay and immunoblotting, respectively. Gastric atrophy was assessed by serum levels of pepsinogen I. Multivariable logistic regression with adjustment for potential confounding factors was used to evaluate associations. Results: H. pylori infection, assayed by HP-CSA or CagA antibodies, was statistically significantly associated with a reduced risk for esophageal adenocarcinoma (for HP-CSA antibodies, odds ratio [OR] = 0.3, 95% confidence interval [CI] = 0.2 to 0.6; for CagA antibodies, OR = 0.5, 95% CI = 0.3 to 0.8; for both, OR = 0.2, 95% CI = 0.1 to 0.5). Gastric atrophy was not associated with the risk for esophageal adenocarcinoma (OR = 1.1, 95% CI = 0.5 to 2.5). Serum CagA antibodies and gastric atrophy were associated with an increased risk for esophageal squamous-cell carcinoma (OR = 2.1, 95% CI = 1.1 to 4.0, and OR = 4.3, 95% CI = 1.9 to 9.6, respectively). The risk of gastric cardia adenocarcinoma was not associated with H. pylori infection. However, gastric atrophy was associated with an increased risk for gastric cardia adenocarcinoma (OR = 4.5, 95% CI = 2.5 to 7.8). Conclusions: Infection with H. pylori may reduce the risk of esophageal adenocarcinoma, but it is unlikely to do so by atrophy-reduced acidity. Gastric atrophy and infection with CagA-positive strains of H. pylori may increase the risk for esophageal squamous-cell carcinoma.
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  M. Giannakis, H. K. Backhed, S. L. Chen, J. J. Faith, M. Wu, J. L. Guruge, L. Engstrand, and J. I. Gordon Response of Gastric Epithelial Progenitors to Helicobacter pylori Isolates Obtained from Swedish Patients with Chronic Atrophic Gastritis J. Biol. Chem., October 30, 2009; 284(44): 30383 - 30394. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J-S Ren, F Kamangar, Y-L Qiao, P R Taylor, H Liang, S M Dawsey, B Liu, J-H Fan, and C C Abnet Serum pepsinogens and risk of gastric and oesophageal cancers in the General Population Nutrition Intervention Trial cohort Gut, May 1, 2009; 58(5): 636 - 642. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. Capella, G. Pera, N. Sala, A. Agudo, F. Rico, G. Del Giudicce, M. Plebani, D. Palli, H. Boeing, H B. Bueno-de-Mesquita, et al. DNA repair polymorphisms and the risk of stomach adenocarcinoma and severe chronic gastritis in the EPIC-EURGAST study Int. J. Epidemiol., December 1, 2008; 37(6): 1316 - 1325. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Veijola, A. Oksanen, P. Sipponen, and H. Rautelin Evaluation of a Commercial Immunoblot, Helicoblot 2.1, for Diagnosis of Helicobacter pylori Infection Clin. Vaccine Immunol., November 1, 2008; 15(11): 1705 - 1710. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. Islami and F. Kamangar Helicobacter pylori and Esophageal Cancer Risk: A Meta-analysis Cancer Prevention Research, October 1, 2008; 1(5): 329 - 338. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D A Corley, A Kubo, T R Levin, G Block, L Habel, W Zhao, P Leighton, G Rumore, C Quesenberry, P Buffler, et al. Helicobacter pylori infection and the risk of Barrett's oesophagus: a community-based study Gut, June 1, 2008; 57(6): 727 - 733. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L A Anderson, S J Murphy, B T Johnston, R G P Watson, H R Ferguson, K B Bamford, A Ghazy, P McCarron, J McGuigan, J V Reynolds, et al. Relationship between Helicobacter pylori infection and gastric atrophy and the stages of the oesophageal inflammation, metaplasia, adenocarcinoma sequence: results from the FINBAR case-control study Gut, June 1, 2008; 57(6): 734 - 739. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Hansen, S. E. Vollset, M. H Derakhshan, V. Fyfe, K. K Melby, S. Aase, E. Jellum, and K. E L McColl Two distinct aetiologies of cardia cancer; evidence from premorbid serological markers of gastric atrophy and Helicobacter pylori status Gut, July 1, 2007; 56(7): 918 - 925. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P Malfertheiner, F Megraud, C O'Morain, F Bazzoli, E El-Omar, D Graham, R Hunt, T Rokkas, N Vakil, E J Kuipers, et al. Current concepts in the management of Helicobacter pylori infection: the Maastricht III Consensus Report Gut, June 1, 2007; 56(6): 772 - 781. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Chen and M. J. Blaser Inverse Associations of Helicobacter pylori With Asthma and Allergy Arch Intern Med, April 23, 2007; 167(8): 821 - 827. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Bahmanyar, K. Zendehdel, O. Nyren, and W. Ye Risk of oesophageal cancer by histology among patients hospitalised for gastroduodenal ulcers Gut, April 1, 2007; 56(4): 464 - 468. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 O. Nyren and W. J. Blot Helicobacter pylori Infection: Mainly Foe but Also Friend? J Natl Cancer Inst, October 18, 2006; 98(20): 1432 - 1434. [Full Text] [PDF]
|
|
|
|
|
|
F. Kamangar, S. M. Dawsey, M. J. Blaser, G. I. Perez-Perez, P. Pietinen, C. J. Newschaffer, C. C. Abnet, D. Albanes, J. Virtamo, and P. R. Taylor Opposing Risks of Gastric Cardia and Noncardia Gastric Adenocarcinomas Associated With Helicobacter pylori Seropositivity. J Natl Cancer Inst, October 18, 2006; 98(20): 1445 - 1452. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. D. Oh, H. Kling-Backhed, M. Giannakis, J. Xu, R. S. Fulton, L. A. Fulton, H. S. Cordum, C. Wang, G. Elliott, J. Edwards, et al. The complete genome sequence of a chronic atrophic gastritis Helicobacter pylori strain: Evolution during disease progression PNAS, June 27, 2006; 103(26): 9999 - 10004. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. A. Gonzalez, P. Jakszyn, G. Pera, A. Agudo, S. Bingham, D. Palli, P. Ferrari, H. Boeing, G. del Giudice, M. Plebani, et al. Meat intake and risk of stomach and esophageal adenocarcinoma within the European Prospective Investigation Into Cancer and Nutrition (EPIC). J Natl Cancer Inst, March 1, 2006; 98(5): 345 - 354. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. F. Souza and S. J. Spechler Concepts in the Prevention of Adenocarcinoma of the Distal Esophagus and Proximal Stomach CA Cancer J Clin, November 1, 2005; 55(6): 334 - 351. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Pohl and H. G. Welch RESPONSE: Re: The Role of Overdiagnosis and Reclassification in the Marked Increase of Esophageal Adenocarcinoma Incidence J Natl Cancer Inst, July 6, 2005; 97(13): 1014 - 1014. [Full Text] [PDF]
|
|
|
|
 |
|
 C. Jansson, A. L.V. Johansson, O. Nyren, and J. Lagergren Socioeconomic Factors and Risk of Esophageal Adenocarcinoma: A Nationwide Swedish Case-Control Study Cancer Epidemiol. Biomarkers Prev., July 1, 2005; 14(7): 1754 - 1761. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. D. Oh, S. M. Karam, and J. I. Gordon Intracellular Helicobacter pylori in gastric epithelial progenitors PNAS, April 5, 2005; 102(14): 5186 - 5191. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J Lagergren Adenocarcinoma of oesophagus: what exactly is the size of the problem and who is at risk? Gut, March 1, 2005; 54(suppl_1): i1 - i5. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Ishikawa, J. Kitayama, S. Kazama, T. Hiramatsu, K. Hatano, and H. Nagawa Plasma Adiponectin and Gastric Cancer Clin. Cancer Res., January 15, 2005; 11(2): 466 - 472. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
JournalScan Gut, July 1, 2004; 53(7): 1054 - 1054. [Full Text] [PDF]
|
|